Charles Albert Dafoe
Physician at Columbine St, Denver, CO

License number
Colorado 14238
Issued Date
Apr 10, 1962
Renew Date
Jun 1, 2003
Expiration Date
May 31, 2005
Type
Physician
Address
Address
860 S Columbine St, Denver, CO 80209

Professional information

Charles Dafoe Photo 1

Method Of Transvaginal Sterilization

US Patent:
4416660, Nov 22, 1983
Filed:
May 2, 1978
Appl. No.:
5/902159
Inventors:
Charles A. Dafoe - Denver CO
International Classification:
A61M 100
US Classification:
604 55
Abstract:
A method for sterilization of females has been devised in which one or more hypodermic needles can be inserted into the uterus to a predetermined position or location at the uterine cornu and the internal tubal ostra followed by injecting a sclerosing agent which produces a chronic lesion at that point. The entire needle assembly is characterized by slidable mounting of the needle or needles within a guide or sleeve projecting forwardly from a disposable cartridge, and a hand-held actuator is provided to selectively control successive advancement of each needle through the needle guide into the tissue and advancement of the ampule or cartridge to force the sclerosing agent or other medicament through the needle. Thereafter, the needle assembly may either be withdrawn or relocated to another position for injection of medicament through the same or other needle advancing through the same needle guide into the opposite cornul portion.


Charles Dafoe Photo 2

Transvaginal Sterilization Instrument

US Patent:
4136695, Jan 30, 1979
Filed:
Jul 9, 1975
Appl. No.:
5/594269
Inventors:
Charles A. Dafoe - Denver CO
Assignee:
Gynetech-Denver, Inc. - Denver CO
International Classification:
A61M 500
US Classification:
128215
Abstract:
A method and instrumentation for sterilization of females has been devised in which one or more hypodermic needles can be inserted into the uterus to a predetermined position or location at the uterine cornu and the internal tubal ostra followed by injecting a sclerosing agent which produces a chronic lesion at that point. The entire needle assembly is characterized by slidable mounting of the needle or needles within a guide or sleeve projecting forwardly from a disposable cartridge, and a hand-held actuator is provided to selectively control successive advancement of each needle through the needle guide into the tissue and advancment of the ampule or cartridge to force the sclerosing agent or other medicament through the needle. Thereafter, the needle assembly may either be withdrawn or relocated to another position for injection of medicament through the same or other needle advancing through the same needle guide into the opposite cornul portion.